Literature DB >> 20723166

Postponing or eliminating red blood cell transfusions of very low birth weight neonates by obtaining all baseline laboratory blood tests from otherwise discarded fetal blood in the placenta.

Robert D Christensen1, Diane K Lambert, Vickie L Baer, Dianne P Montgomery, Cindy K Barney, David M Coulter, Sarah Ilstrup, Sterling T Bennett.   

Abstract

BACKGROUND: Safely reducing the proportion of very low birth weight neonates (<1500 g) that receive a red blood cell (RBC) transfusion would be an advance in transfusion practice. STUDY DESIGN AND METHODS: We performed a prospective, single-centered, case-control, feasibility analysis, preparatory to designing a definitive trial. Specifically, we sought to determine whether we could obtain all baseline neonatal intensive care unit blood tests from the placenta, after placental delivery, thereby initially drawing no blood from the neonate.
RESULTS: Ten cases where all baseline blood tests were drawn from the placenta, and 10 controls where all tests were drawn from the neonate, were closely matched for birth weight, gestational age, sex, and race. Early cord clamping was used for all 20. Over the first 18 hours the hemoglobin increased in nine cases versus two controls (p = 0.005). During the first 72 hours one case versus five controls qualified for and received an RBC transfusion. In the first week the cases received four transfusions and the controls received 16 (p = 0.02). None of the cases had an intraventricular hemorrhage (IVH) but four of the controls had a Grade 1 and two had a Grade 3 (p = 0.01).
CONCLUSION: We speculate that this method is feasible and generally postpones the first RBC transfusion until beyond the period of peak vulnerability to IVH.
© 2010 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20723166     DOI: 10.1111/j.1537-2995.2010.02827.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  6 in total

1.  Whole-blood viscosity in the neonate: effects of gestational age, hematocrit, mean corpuscular volume and umbilical cord milking.

Authors:  R D Christensen; V L Baer; E Gerday; M J Sheffield; D S Richards; J G Shepherd; G L Snow; S T Bennett; E L Frank; W Oh
Journal:  J Perinatol       Date:  2013-09-12       Impact factor: 2.521

Review 2.  Nonpharmacological, blood conservation techniques for preventing neonatal anemia--effective and promising strategies for reducing transfusion.

Authors:  Patrick D Carroll; John A Widness
Journal:  Semin Perinatol       Date:  2012-08       Impact factor: 3.300

3.  A randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infants.

Authors:  Robin K Ohls; Robert D Christensen; Beena D Kamath-Rayne; Adam Rosenberg; Susan E Wiedmeier; Mahshid Roohi; Conra Backstrom Lacy; Diane K Lambert; Jill J Burnett; Barbara Pruckler; Ron Schrader; Jean R Lowe
Journal:  Pediatrics       Date:  2013-06-17       Impact factor: 7.124

Review 4.  New and underutilized uses of umbilical cord blood in neonatal care.

Authors:  Patrick D Carroll; Robert D Christensen
Journal:  Matern Health Neonatol Perinatol       Date:  2015-06-16

5.  Eliminating Contamination in Umbilical Cord Blood Culture Sampling for Early-Onset Neonatal Sepsis.

Authors:  Vilmaris Quinones Cardona; Vanessa Lowery; David Cooperberg; Endla K Anday; Alison J Carey
Journal:  Front Pediatr       Date:  2021-12-20       Impact factor: 3.418

6.  The Novel Use of Umbilical Cord Blood to Obtain Complete Blood Counts for Critical Neonatal Assessment.

Authors:  Alexandra P Hansen; Gayle D Haischer-Rollo; Jonathan B Shapiro; James K Aden; Jude M Abadie; Thornton S Mu
Journal:  Cureus       Date:  2022-08-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.